Monday, Jan 26, 2026 · SEC filings
What the smart money revealed on Jan 26
351 insider filings came in. We hid 39 planned (10b5-1) sellers and 268 people whose filings were routine, like grants and tax withholding.
Abbott Laboratories (ABT) Chairman and CEO Robert Ford bought $2.01M
18,800 shares on the open market. Not a grant or an option exercise.
TCW Private Asset Income Fund Director Robert Rooney bought $394K
39,367 shares on the open market. Not a grant or an option exercise.
Cel Sci (CVM) CEO Geert Kersten bought $200K
38,023 shares on the open market. Not a grant or an option exercise.
Streamex (STEX) Chief Investment Officer Mitchell Williams bought $156K
51,511 shares on the open market. Not a grant or an option exercise.
Interactive Brokers Group (IBKR) Vice Chairman Earl Nemser sold $19M
Not marked as a planned 10b5-1 sale. Sold 61% of the shares they held directly. Still holds 155,000 shares.
Procter & Gamble (PG) Chief Brand Officer Marc Pritchard sold $14.5M
Not marked as a planned 10b5-1 sale. Sold 34% of the shares they held directly. Still holds 182,607 shares.
Taylor Devices (TAYD) Director Fritz Armenat sold $311K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 6 more real buys
Show 13 more real sales
13F season
Holdings as of Dec 31, 2025 are due Feb 17
320 funds have filed so far. 81 filed for the quarter before.
Biggest real insider buys this week
Open-market buys by officers and directors, filed in the 7 days up to Jan 26.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.